A review of the role of capecitabine in the treatment of colorectal cancer.

about

Cytotoxicity and genotoxicity of capecitabine in head and neck cancer and normal cells.

P2860

Q39627590-F551799C-652E-4F0E-819E-7A9D5FB61811

P2860

A review of the role of capecitabine in the treatment of colorectal cancer.

Item

http://www.wikidata.org/entity/Q36661290

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

A review of the role of capecitabine in the treatment of colorectal cancer.

@ast

A review of the role of capecitabine in the treatment of colorectal cancer.

@en

type

Item

label

A review of the role of capecitabine in the treatment of colorectal cancer.

@ast

A review of the role of capecitabine in the treatment of colorectal cancer.

@en

prefLabel

A review of the role of capecitabine in the treatment of colorectal cancer.

@ast

A review of the role of capecitabine in the treatment of colorectal cancer.

@en

P1476

A review of the role of capecitabine in the treatment of colorectal cancer

@en

P2093

Pasquale Comella

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

Cancer statistics, 2005

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer.

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

P304

421-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18488072

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2386354

http://www.w3.org/2001/XMLSchema#string

A review of the role of capecitabine in the treatment of colorectal cancer.

about

P2860

P2860

A review of the role of capecitabine in the treatment of colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932